World Drug Safety Congress Americas 2022

Indegene will be at the World Drug Safety Congress Americas 2022 in Boston. Forward-thinking sessions and eleven tracks will address the application of new technologies and methods to streamline operations with an objective to co-create, solve problems, and discuss global and local challenges faced by safety professionals.

04 - 05 October 2022
Sheraton Boston, Boston, MA
World Drug Safety Congress Americas 2022

Meet our experts at booth #39

 
Sameer Lal
Sameer Lal
Senior Vice President, Enterprise Medical Business Unit
Nikesh Shah
Nikesh Shah
Vice President - Medical Solutions and Market Access
Vladimir Penkrat
Vladimir Penkrat
Associate Vice President - Global Head of Safety & Regulatory Affairs
Kedar Joshi
Kedar Joshi
Associate Vice President - Global Client Partner
Shubha Rao
Dr. Shubha Rao
Senior Director - Medical Solutions 
 
 
 

Our Sessions

Roundtable Session: Can PV Operations manage and measure the automation roadmap to intelligence without risk?

Session Brief: Many organizations are preparing or have already started on a path to apply automation into the ICSR process but success can come with risk to compliance in operations, delays in technology deployment, and cost over runs. Frequently PV organizations aspire to create impact but settle on efficiency outcomes; falling short on longer term goals of improving intelligence through automation. A truly effective plan to transform PV from transactional to intelligent needs to consider organizational and technical readiness and the mindset of how technology can be applied to deliver desired outcomes. In the course of this presentation attendees will gain insights on defining, managing the change, and achieving intelligent ICSR operations that extends beyond incremental impact in efficiency.

Schedule: 1:40 PM ET, 4th October

About the event

World Drug Safety Congress Americas 2022 
04 - 05 October 2022 
Sheraton Boston, Boston, MA

The World Drug Safety Congress Americas will bring together 1000+ top leaders and stakeholders in biopharma to discuss the key challenges they are facing in pharmacovigilance and device safety. An opportunity to explore the use of big data and AI in pharmacovigilance, examine benefit-risk management strategies and patient-centric approaches; discuss how you can tackle the challenges of social media and drug safety legislation globally. This conference is the largest commercial gathering of PV professionals in the world.

Visit the Website